Showing results (2041-2050 of 2,317) with videos related to

Sort By:
Pageof 232
Talanta|October 14, 2015
Paper-based ELISA to rapidly detect Escherichia coliCheng-Min Shih, Chia-Ling Chang, Min-Yen Hsu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 22, 2017
Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinomaChun-Nan Yeh, Chi-Wei Chang, Yi-Hsiu Chung, et al.
Biomaterials|February 7, 2013
[123I]Iodooctyl fenbufen amide as a SPECT tracer for imaging tumors that over-express COX enzymesHo-Lien Huang, Chun-Nan Yeh, Wei-Yuan Lee, et al.
Quality Management in Health Care|March 26, 2024
Effectiveness of Huddles in Improving the Patient Safety Attitudes Among Clinical Team MembersYi-Hung Lai, Ching-Wein Chang, Ming-Ju Wu, et al.
BMC Genomics|July 15, 2016
Nosocomial transmission of Clostridium difficile ribotype 027 in a Chinese hospital, 2012-2014, traced by whole genome sequencingHongbing Jia, Pengcheng Du, Hui Yang, et al.
Organic & Biomolecular Chemistry|June 6, 2018
Regioselective synthesis and biological evaluation of N-substituted 2-aminoquinazolin-4-onesZhen-Yuan Liao, Wen-Hsiung Yeh, Pen-Yuan Liao, et al.
Clinical Lung Cancer|June 20, 2025
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203)Jia-Xin Lin, Qing Zhou, Hong-Hong Yan, et al.
The Journal of Infectious Diseases|May 8, 2024
Informing the Need for a SARS-CoV-2 Booster Based on the Immune Responses Among Young Healthy Adults to Variants Circulating in Late 2023Huy C Nguyen, Kerri G Lal, Corey A Balinsky, et al.
The Journal of Craniofacial Surgery|August 20, 2019
Comprehensive Application of Autologous Costal Cartilage Grafts in Rhino- and MentoplastyLu Zhang, Wen-Shu Ma, Ji-Ping Bai, et al.
Chinese Medical Journal|April 12, 2012
Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA studyBing-he Xu, Ze-fei Jiang, Zhen-zhou Shen, et al.
Pageof 232